Yasmin Barazandegan

Dr. Yasmin Barazandegan

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2025 in Toxics
Verified
Journal Article
Open access
PDF file
PMPietro Martano
Pietro Martano
SMSamira Mahdi
Samira Mahdi
TZTong Zhou
Tong Zhou
YBYasmin Barazandegan
Yasmin Barazandegan
RIRebecca Iha
Rebecca Iha
Ray MuRay Mu
Ray Mu
Per- and polyfluoroalkyl substances (PFASs) have gained significant attention due to their widespread distribution in the environment and potential adverse health effects. While ingestion, especially through contaminated drinking water, is considered the primary route of human exposure, recent research suggests that other pathways, such as inhalation and dermal absorption, also play a significant role. This review provides a concise overview of the toxicological impacts of both legacy and emerging PFASs, such as GenX and perfluorobutane sulfonic acid (PFBS), with a particular focus on their effects on the liver, kidneys, and immune and nervous systems, based on findings from recent in vivo, in vitro, and epidemiological studies. Despite the transition to PFAS alternatives, much of the existing toxicity data focus on a few legacy compounds, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), which have been linked to adverse immune outcomes, particularly in children. However, evidence for carcinogenic risk remains limited to populations with extremely high exposure levels, and data on neurodevelopmental effects remain underexplored. While epidemiological and experimental animal studies supported these findings, significant knowledge gaps persist, especially regarding emerging PFASs. Therefore, this review examines the visceral, neural, and immunotoxicity data for emerging PFASs and mixtures from recent studies. Given the known risks from well-studied PFASs, a precautionary principle should be adopted to mitigate human health risks posed by this large and diverse group of chemicals.

15 June 2026 in Micromachines
Verified
Journal Article
Open access
PDF file
YBYasmin Barazandegan
Yasmin Barazandegan
DKDipsana KC
Dipsana KC
RIRebecca Iha
Rebecca Iha
NTNiya Tu
Niya Tu
NRNadia Ryan
Nadia Ryan
Qingbo (Roger) YangQingbo (Roger) Yang
Qingbo (Roger) Yang
Bionic sensors are emerging as powerful analytical platforms driving the development of next-generation detection technologies, particularly for small molecule sensing in complex environmental and biological systems. However, accurate and selective detection of small molecules remains fundamentally challenging due to their low molecular weight, limited structural specificity, and strong interference from complex matrices. This review provides a comprehensive overview of recent advances in bionic sensor technologies, focusing on how the integration of synthetic biology, nanomaterials, and artificial intelligence (AI) addresses these limitations. Key biorecognition elements, including enzymes, antibodies, aptamers, and molecularly imprinted polymers, are examined for their suitability in small molecule sensing applications. Advances in nanomaterials such as graphene, carbon nanotubes, quantum dots, and MXenes are discussed in relation to signal transduction enhancement, sensitivity improvement, and device miniaturization. In parallel, the roles of AI and machine learning in signal denoising, adaptive calibration, and molecular fingerprinting for complex datasets are highlighted. Applications in wearable and implantable biosensors, environmental monitoring, and food safety are analyzed, emphasizing real-time detection of metabolites, pollutants, and toxins. Key challenges associated with AI-driven systems, including scalability, cost, data reliability, and ethical concerns, are also discussed. Emerging trends such as hybrid sensing platforms, self-powered biosensors, and secure data integration frameworks are presented as future directions. This review aims to provide a problem-driven perspective on how next-generation bionic sensors can overcome current limitations and enable robust small molecule detection in real-world applications.